Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2001, p. 3530-3536, Vol. 39, No. 10
Roche Molecular Systems, Alameda,
California,1 and Department of
Epidemiology and Biostatistics, McGill
University,2 Unité de Maladies
Infectieuses, Direction de la Santé Publique de
Montréal-Centre,3
Départements de Microbiologie et de Pédiatrie,
Université de Montréal,4
Centre Maternel et Infantile sur le SIDA, Centre de Recherche
de l'Hôpital Sainte-Justine, Hôpital
Sainte-Justine,5 and Département
de Microbiologie et Infectiologie, Hôpital Notre-Dame du
Centre Hospitalier de l'Université de
Montréal,6 Montreal, Quebec, Canada
Received 5 March 2001/Returned for modification 19 April
2001/Accepted 9 July 2001
We assessed the value of a new digoxigenin (DIG)-labeled generic
probe mix in a PCR-enzyme-linked immunosorbent assay format to screen
for the presence of human papillomavirus (HPV) DNA amplified from
clinical specimens. After screening with this new generic assay is
performed, HPV DNA-positive samples can be directly genotyped using a
reverse blotting method with product from the same PCR amplification.
DNA from 287 genital specimens was amplified via PCR using
biotin-labeled consensus primers directed to the L1 gene. HPV amplicons
were captured on a streptavidin-coated microwell plate (MWP) and
detected with a DIG-labeled HPV generic probe mix consisting of nested
L1 fragments from types 11, 16, 18, and 51. Coamplification and
detection of human DNA with biotinylated
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.10.3530-3536.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Nonisotopic Detection of Human Papillomavirus DNA in Clinical
Specimens Using a Consensus PCR and a Generic Probe Mix in an
Enzyme-Linked Immunosorbent Assay Format
and
-globin primers served as a
control for both sample adequacy and PCR amplification. All specimens
were genotyped using a reverse line blot assay (13). Results for the
generic assay using MWPs and a DIG-labeled HPV generic probe mix
(DIG-MWP generic probe assay) were compared with results from a
previous analysis using dot blots with a radiolabeled nested generic
probe mix and type-specific probes for genotyping. The DIG-MWP generic
probe assay resulted in high intralaboratory concordance in genotyping
results (88% versus 73% agreement using traditional methods). There
were 207 HPV-positive results using the DIG-MWP method and 196 positives using the radiolabeled generic probe technique, suggesting
slightly improved sensitivity. Only one sample failed to test positive with the DIG-MWP generic probe assay in spite of a positive genotyping result. Concordance between the two laboratories was nearly 87%. Approximately 6% of samples that were positive or borderline when tested with the DIG-MWP generic probe assay were not detected with the
HPV type-specific panel, perhaps representing very rare or novel HPV
types. This new method is easier to perform than traditional generic
probe techniques and uses more objective interpretation criteria, making it useful in studies of HPV natural history.
*
Corresponding author. Mailing address: Roche Molecular
Systems, 1145 Atlantic Ave., Alameda, CA 94501. Phone: (510) 814-2749. Fax: (510) 522-1285. E-mail: janet.kornegay{at}roche.com.
The Canadian Women's HIV Study Group includes the following
investigators throughout Canada: principal investigators, Catherine Hankins and Normand Lapointe; Calgary, John Gill; Edmonton, Barbara Romanowski and Stephen Shafran; Halifax, Rob Grimshaw, David Haase, Lynn Johnston, and Wally Schlech; Hamilton, Stephan Landis, John Sellors, and Fiona Smaill; Montréal, François Beaudoin,
Ngoc Biu, Alena Capek, Marc Boucher, Michel Chateauvert, Manon
Coté, François Coutlée, Douglas Dalton, Gretty
Deutsch, Julian Falutz, Diane Francoeur, Lisa Hallman, Eleanor Hew,
Lina Karayan,
Marina Klein, Louise Labrecque, Richard Lalonde, Christiane
Lavoie, Catherine Lounsbury, John Macleod, Nicole Marceau, Gail
Myhr, Grégoire Noel, Robert Piché, Manisha Raut, Chantal
Rondeau, Jean-Pierre Routy, Karoon Samikian, Pierre Simard, Christina
Smeja, Graham Smith, Paul-Pierre Tellier, and Emil Toma; Ottawa, Garry
Garber and Garry Victor; Québec, Louise Côté, Edith
Guilbert, Michel Morissette, Hélène Senay, and Sylvie
Trottier; Toronto, Phil Berger, Lisa Friedland, Donna Keystone, Joan
Murphy, Anne Phillips, Marion Powell, Anita Rachlis, Pat Rockman,
Irving Salit, Cheryl Wagner, and Sharon Walmsey; Saskatoon, Kurt
Williams; St. John, Ian Bowmer and Rory Windrim; Sudbury, Roger Sandre;
Vancouver, Penny Ballem, David Burdge, Brian Conway, Mariane Harris,
Deborah Money, Julio Montaner, Deborah Money, and Janice Veenhuizen.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»